If you have celiac disease and currently have kidney stones, or have had kidney stones in the past, you may be eligible for a new clinical research study!

The Celiac Disease Foundation Young Investigator Research Grant Award is a one- to three-year grant totaling up to $180,000. The purpose of the Award is to encourage exceptional investigators to pursue independent careers in celiac disease research.

Celiac Disease Foundation quoted in Healthline article covering the Nexvax2 therapeutic vaccine candidate.

In a Medscape Gastroenterology article covering Digestive Disease Week (DDW) 2018, William Balistreri, MD, reported on the studies presented that addressed reliable, cost-effective celiac disease detection. One of the studies highlighted in the article, Forgoing the Duodenal Biopsy for Celiac Disease Diagnosis Among Adults in the United States: Results of a National Survey, analyzed data…

ImmusanT, Inc., announces first patient dosed in Phase 2 clinical trial, RESET CeD, testing the safety and efficacy of Nexvax2®, a therapeutic vaccine for the treatment of celiac disease patients.